Liver fibrosis is a chronic liver disease characterized by the proliferation and activation of
hepatic stellate cells (HSCs) and excessive deposition of extracellular matrix (ECM) …

Background/Aims: The activation of hepatic stellate cells (HSCs) is considered as a pivotal
event in liver fibrosis and epithelial-mesenchymal transition (EMT) process has been …

Liver fibrosis is a major endpoint of patients with chronic liver diseases. The molecular
mechanisms behind liver fibrosis remain largely unknown. Many studies have indicated the …

Liver fibrosis is a common pathological process of end-stage liver diseases. However, the
role of microRNA (miRNA) in liver fibrosis is poorly understood. The activated hepatic …

Hepatic stellate cell (HSC) activation is a pivotal event in the initiation and progression of
hepatic fibrosis since it mediates transforming growth factor beta 1 (TGF-β1)-driven …

BACKGROUND Activation of hepatic stellate cells (HSCs) is a pivotal event in the onset and
progression of liver fibrosis. Loss of microRNA-194 (miR-194) has been reported in …

Accumulating research have indicated that microRNAs are associated with the progression
of hepatic fibrosis (HF). Nevertheless, the biological role and function of microRNA (miR) …

Abstract microRNA-29b (miR-29b) is known to be associated with TGF-β-mediated fibrosis,
but the mechanistic action of miR-29b in liver fibrosis remains unclear and is warranted for …

There has been an increasing number of researches about microRNAs (miRNAs) in the
progression of liver fibrosis from the point of their comprehensive functions in regulating the …

Liver fibrosis is a major cause of morbidity and mortality worldwide, and the outcome of
various chronic liver diseases. Recent studies suggest that aberrant expression of miR‐34 is …